LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

Search

STERIS PLC

Abrir

SetorSaúde

247.85 -0.1

Visão Geral

Variação de preço das ações

24h

Atual

Mín

247.36

Máximo

249.41

Indicadores-chave

By Trading Economics

Rendimento

32M

178M

Vendas

-89M

1.4B

P/E

Médio do Setor

37.936

35.724

EPS

2.34

Rendimento de Dividendos

0.91

Margem de lucro

12.796

Funcionários

17,787

EBITDA

-89M

248M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+12.53% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.91%

3.09%

Próxima data de dividendos

26 de set. de 2025

Próxima data de ex-dividendo

4 de set. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

2B

24B

Abertura anterior

247.95

Fecho anterior

247.85

Sentimento de Notícias

By Acuity

44%

56%

155 / 372 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bearish Evidence

STERIS PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

6 de ago. de 2025, 20:30 UTC

Ganhos

Steris 1Q Adj EPS $2.34 >STE

6 de ago. de 2025, 20:30 UTC

Ganhos

Steris 1Q Rev $1.4B >STE

14 de mai. de 2025, 20:30 UTC

Ganhos

Steris Sees FY Adj EPS $9.90-Adj EPS $10.15 >STE

14 de mai. de 2025, 20:30 UTC

Ganhos

Steris 4Q Rev $1.5B >STE

14 de mai. de 2025, 20:30 UTC

Ganhos

Steris 4Q Adj EPS $2.74 >STE

5 de fev. de 2025, 21:35 UTC

Ganhos

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

5 de fev. de 2025, 21:34 UTC

Ganhos

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

5 de fev. de 2025, 21:34 UTC

Ganhos

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

5 de fev. de 2025, 21:33 UTC

Ganhos

Steris 3Q EPS $1.75 >STE

5 de fev. de 2025, 21:30 UTC

Ganhos

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

5 de fev. de 2025, 21:30 UTC

Ganhos

Steris 3Q Rev $1.4B >STE

5 de fev. de 2025, 21:30 UTC

Ganhos

Steris 3Q Adj EPS $2.32 >STE

6 de nov. de 2024, 21:41 UTC

Ganhos

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

6 de nov. de 2024, 21:40 UTC

Ganhos

Steris 2Q EPS $1.51 >STE

6 de nov. de 2024, 21:30 UTC

Ganhos

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

6 de nov. de 2024, 21:30 UTC

Ganhos

Steris 2Q Adj EPS $2.14 >STE

6 de nov. de 2024, 21:30 UTC

Ganhos

Steris 2Q Rev $1.3B >STE

Comparação entre Pares

Variação de preço

STERIS PLC Previsão

Preço-alvo

By TipRanks

12.53% parte superior

Previsão para 12 meses

Média 280.17 USD  12.53%

Máximo 295 USD

Mínimo 263 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para STERIS PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

7 ratings

5

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

225 / 226.35Suporte e Resistência

Curto Prazo

Bearish Evidence

Médio Prazo

Strong Bullish Evidence

Longo Prazo

Strong Bullish Evidence

Sentimento

By Acuity

155 / 372 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.